<rows>
  <row id="1061499" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<div sys_relationshipid="7315949" sys_dependentid="1088990" rxinlineslot="105" contenteditable="false" sys_dependentvariantid="2066" rxselectedtext="" rxanchortext="" unselectable="on" inlinetype="rxvariant" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable">
          <figure class="image-right-medium centered-set">        <div class="centered-element">                      <img src="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=3&amp;sys_authtype=0&amp;sys_variantid=1482&amp;sys_context=0&amp;sys_folderid=1052690&amp;sys_siteid=305&amp;sys_contentid=1088990&amp;sys_command=preview" alt=""><!--Comment--></img>
                                                </div>
                  <figcaption>
            <div class="caption-container no-resize">
                              
<p>The image is an electron micrograph of a suspended microchannel resonant (SMR) mass sensor under development by researchers at the MIT-Harvard CCNE/CNPP. This sensor is being developed for label-free detection of cancer biomarkers.</p>
                                            <div class="image-photo-credit">Credit: National Cancer Institute</div>                          </div>
          </figcaption>
              </figure>
       </div>
<p></p>
<p>Funding opportunities currently available from the NCI&nbsp;Nanodelivery Systems and Devices Branch&nbsp;for the NCI Alliance for Nanotechnology in Cancer (link for downloadable Factsheet) are accessible from <a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1064733" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="1764" rxinlineslot="103" sys_dependentid="1064733" sys_relationshipid="7315942" sys_variantid="1764" sys_contentid="1064733">Apply to Alliance</a> and other opportunities are accessible from <a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1063327" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="1764" rxinlineslot="103" sys_dependentid="1063327" sys_relationshipid="7315943" sys_variantid="1764" sys_contentid="1063327">Research Funding</a> below.</p>
<p>Similarly, funding for specific research or training opportunities within the field of cancer nanotechnology or fields that contain much cross-sectional overlap to cancer nanotechnology may be accessed from either <a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1063327" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="1764" rxinlineslot="103" sys_dependentid="1063327" sys_relationshipid="7315944" sys_variantid="1764" sys_contentid="1063327">Related NCI Funding and Initiatives</a> or <a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=7&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1063349" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="1764" rxinlineslot="103" sys_dependentid="1063349" sys_relationshipid="7315945" sys_variantid="1764" sys_contentid="1063349">Training Grants</a> below. These opportunities are from across the NIH and are offered here as a resource to the research community. Also, you may visit the <a href="https://grants.nih.gov/funding/index.htm">NIH Guide for Grants and Contracts</a> for the latest publication of all NIH funding opportunities and notices.</p>
</div>]]></body>
  </row>
  <row id="1071465" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>Currently, scientists are limited in their ability to turn promising molecular discoveries into cancer patient benefits. Nanotechnology &mdash;the science and engineering of controlling matter, at the molecular scale, to create devices with novel chemical, physical and/or biological properties&mdash; can provide technical control and tools to enable the development of new diagnostics, therapeutics, and preventions that keep pace with today&rsquo;s explosion in knowledge.</p>
<p>Nanotechnology has the potential to radically change how we diagnose and treat cancer. Although scientists and engineers have only recently (ca. 1980's) developed the ability to industrialize technologies at this scale, there has been good progress in translating nano-based cancer therapies and diagnostics into the clinic and many more are in development.</p>
<p>Nanotechnology is the application of materials, functionalized structures, devices, or systems at the atomic, molecular, or macromolecular scales. At these length scales, approximately the 1-100 nanometer range as defined by the <a href="http://www.nano.gov/">U.S. National Nanotechnology Initiative (NNI)</a> , unique and specific physical properties of matter exist, which can be readily manipulated for a desired application or effect. Furthermore, nanoscale structure can be used as individual entities or integrated into larger material components, systems, and architectures.</p>
<div sys_relationshipid="6886915" sys_dependentid="1091245" rxinlineslot="105" contenteditable="false" sys_dependentvariantid="2084" rxselectedtext="" rxanchortext="" unselectable="on" inlinetype="rxvariant" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable">
          <figure class="image-center-full centered-set">        <div class="centered-element">                      <img src="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=1482&amp;sys_context=0&amp;sys_folderid=1052690&amp;sys_siteid=305&amp;sys_contentid=1091245&amp;sys_command=preview" alt=""><!--Comment--></img>
                                                </div>
                  <figcaption>
            <div class="caption-container no-resize">
                              
<p>Nanoscale devices are one hundred to ten thousand times smaller than human cells.&nbsp; The depiction displays this scale in size.</p>
                                            <div class="image-photo-credit">Credit: National Cancer Institute</div>                          </div>
          </figcaption>
              </figure>
       </div>
<p>This emerging field involves scientists from many different disciplines, including physicists, chemists, engineers, information technologists, and material scientists, as well as biologists. Nanotechnology is being applied to almost every field imaginable, including electronics, magnetics, optics, information technology, materials development and biomedicine. Nanotechnology-based structures and devices are already enabling a large number of novel applications in various fields &ndash; including medicine.</p>
</div>]]></body>
  </row>
  <row id="1071471" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>The primary purpose of the <em>Cancer Nanotechnology Plan 2015</em> is to serve as a strategic document to the <a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=6&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2317&amp;sys_contentid=1051623" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="2317" rxinlineslot="103" sys_dependentid="1051623" sys_relationshipid="7357461" sys_variantid="2317" sys_contentid="1051623">NCI Alliance for Nanotechnology in Cancer</a> as well as a guiding document to the cancer nanotechnology and oncology fields, as a whole. Now in its third incarnation, it has increased in its scope since its inception in 2005, mostly due to the fact that the field has significantly matured and expanded over this time. It includes contributions from researchers, clinicians, policy makers, and industrial experts in order to give a broad perspective on where the field is now and where it is heading in the future. The plan is also available in a reduced form as a slide presentation to train others as to the field and future potential for clinical cancer care.</p>
<p>The Cancer Nanotechnology Plan is available for download through the links below:</p>
</div>]]></body>
  </row>
  <row id="1071491" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>Biological processes, including ones necessary for life and those that lead to cancer, occur at the nanoscale. Thus, in fact, we are composed of a multitude of biological nano-machines. Nanotechnology provides researchers with the opportunity to study and manipulate macromolecules in real time and during the earliest stages of cancer progression. Nanotechnology can provide rapid and sensitive detection of cancer-related molecules, enabling scientists to detect molecular changes even when they occur only in a small percentage of cells. Nanotechnology also has the potential to generate entirely novel and highly effective therapeutic agents.&nbsp;</p>
<p></p>
<div sys_dependentvariantid="2489" sys_dependentid="1078447" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="6655234"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list">
<ul>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2289&amp;sys_context=0&amp;sys_folderid=1051366&amp;sys_siteid=305&amp;sys_contentid=1051623&amp;sys_command=edit">NCI Alliance for Nanotechnology in Cancer</a><!-- start description -->
<div class="description">
<p class="body">Launched in 2004, the NCI Alliance for Nanotechnology in Cancer program is a comprehensive, structured effort, encompassing the public and private sector to converge multidisciplinary research in nanotechnology to advance the fight against cancer.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1064728&amp;sys_siteid=305&amp;sys_contentid=1064730&amp;sys_command=edit">Research Published by NCI Alliance</a><!-- start description -->
<div class="description">
<p class="body">Published research is the cornerstone of scientific endeavors. The Alliance has a strong track record for publishing high-impact science and engineering.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1077667&amp;sys_siteid=305&amp;sys_contentid=1077669&amp;sys_command=edit">Companies Formed by PIs of the NCI Alliance for Nanotechnology in Cancer</a><!-- start description -->
<div class="description">
<p class="body">The outlet by which technologies go from bench-to-bedside is by way of commercialed intelectual property. The translational success of Alliance investigators begins with this step.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1051372&amp;sys_siteid=305&amp;sys_contentid=1051475&amp;sys_command=edit">Data Sharing</a><!-- start description -->
<div class="description">
<p class="body">A well-organized, collaborative system of data sharing is critical in the translation of nanotechnology research into commercially viable therapeutics and diagnostics to treat patients.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051354&amp;sys_siteid=305&amp;sys_contentid=1077670&amp;sys_command=edit">Nanotechnology Characterization Laboratory (NCL)</a><!-- start description -->
<div class="description">
<p class="body">The Nanotechnology Characterization Laboratory (NCL) is accelerating the development of promising nanotechnology therapies and diagnostics.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1051352&amp;sys_siteid=305&amp;sys_contentid=1051471&amp;sys_command=edit">Cancer Nanotechnology Plan</a><!-- start description -->
<div class="description">
<p class="body">The Cancer Nanotechnology Plan serves as a strategic document to the NCI Alliance for Nanotechnology in Cancer as well as a guiding document to the cancer nanotechnology and oncology fields, as a whole.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1051350&amp;sys_siteid=305&amp;sys_contentid=1051489&amp;sys_command=edit">OCNR Partners and Collaborators</a><!-- start description -->
<div class="description">
<p class="body">Translation of nanotechnology for cancer to the clinic has many hurdles. The OCNR partners with private, academic, and government entities to promote commercialization of nanotechnology for cancer applications.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
</ul>
</div>
</div>
</div>]]></body>
  </row>
  <row id="1071493" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>The multi-disciplinary CCNE teams are the main venue for the discovery and tool development toward the application of nanotechnology to clinical oncology. Teams are focused on integrated technology solutions and the aggressive development of these solutions from pre-clinical to clinical application. These are multiple project centers and are designed to enable multi-disciplinary team research by linking physical scientists, engineers and technologists working at the nanoscale with cancer biologists and oncologists specializing in the diagnosis, prevention and treatment of cancer.</p>
<p></p>
<div sys_dependentvariantid="2489" sys_dependentid="1091244" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="6654462"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list">
<ul>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051398&amp;sys_siteid=305&amp;sys_contentid=1051518&amp;sys_command=edit">Cal Tech &amp; UCLA &mdash; Nanosystems Biology Cancer Center (NSBCC)</a><!-- start description -->
<div class="description">
<p class="body">Designs and develops nanotherapies and nanotech tools to guide selection of combination cancer immunotherapy and targeted therapy treatments for brain cancers and melanoma.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051400&amp;sys_siteid=305&amp;sys_contentid=1051519&amp;sys_command=edit">Northwestern University &mdash; Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer</a><!-- start description -->
<div class="description">
<p class="body">Focuses on the design, synthesis, characterization, and development of spherical nucleic acid constructs as effective nanotherapeutic, single-entity agents for the treatment of glioblastoma multiforme and prostate cancers.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051394&amp;sys_siteid=305&amp;sys_contentid=1051520&amp;sys_command=edit">Sloan Kettering and Cornell University &mdash; MSKCC-Cornell Center for Translation of Cancer Nanomedicine</a><!-- start description -->
<div class="description">
<p class="body">Will enable MM treatment outcomes with minimal off-target toxicity by developing novel nanotherapeutics that combine unique drug delivery mechanisms with spatiotemporal treatment paradigms.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051390&amp;sys_siteid=305&amp;sys_contentid=1051521&amp;sys_command=edit">Stanford University &mdash; Center of Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TR)</a><!-- start description -->
<div class="description">
<p class="body">The overarching focus is to develop and utilize in vitro nanosensors and in vivo molecular imaging tools to advance methods in earlier detection of aggressive cancers as well as monitoring response to therapy for both prostate and lung cancers.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051408&amp;sys_siteid=305&amp;sys_contentid=1051522&amp;sys_command=edit">University of North Carolina, Chapel Hill &mdash; Nano Approaches to Modulate Host Cell Response for Cancer Therapy</a><!-- start description -->
<div class="description">
<p class="body">Will exploit host responses by way of nanoscale approaches for disease management and treatment of melanoma and lung cancer.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051392&amp;sys_siteid=305&amp;sys_contentid=1051523&amp;sys_command=edit">Washington University &mdash; Center for Multiple Myeloma Nanotherapy (CNMN)</a><!-- start description -->
<div class="description">
<p class="body">Advancment and translation of a suite of ultrasmall (&lt;10 nm="" fluorescent="" silica="" organic="" hybrid="" nanoparticles="" cornell="" dots="" with="" tunable="" size="" brightness="" and="" geometry="" that="" will="" dramatically="" impact="" diagnosis="" and="" treatment="" of="" melanoma="" and="" more="" p=""&gt;<!--10--></p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
</ul>
</div>
</div>
</div>]]></body>
  </row>
  <row id="1071494" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>The IRCNs address major barriers in cancer biology and oncology using nanotechnology approaches, and emphasize fundamental understanding of nanomaterial and nanodevice interactions with biological systems in vivo. The individual, circumscribed research projects are designed to enable multi-disciplinary team research and transformative discoveries in cancer biology and oncology, diagnostics, and therapeutics through the use of nanotechnology.</p>
<p>The outcomes of IRCN-supported projects are expected to better inform, inspire, and aid in the development of innovative, clinically relevant nanotechnology solutions for cancer through a greater understanding of these interaction mechanisms. To advance these nanotechnologies, the IRCN projects take advantage of the collaborative environment of the Alliance network.</p>
<p></p>
<div sys_dependentvariantid="2489" sys_dependentid="1091243" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="6766449"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list">
<ul>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051414&amp;sys_siteid=305&amp;sys_contentid=1051570&amp;sys_command=edit">Case Western Reserve University &mdash;Treatment of Glioblastoma Using Chain-Like Nanoparticles</a><!-- start description -->
<div class="description">
<p class="body">Synergistic activity of of iron oxide nanospheres and a drug-loaded liposomes targeted to GBM vasculature and glioma stem cells will facilitate effective treatment and ultimately eradication of the disease using a safe dose of the drugs.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051404&amp;sys_siteid=305&amp;sys_contentid=1051572&amp;sys_command=edit">Emory University &mdash; Stroma Breaking Theranostic Nanoparticles for Targeted Pancreatic Cancer Therapy</a><!-- start description -->
<div class="description">
<p class="body">This project develops a dual-targeted and stroma breaking theranostic nanoparticle platform to address an unmet, clinical challenge of poor drug delivery efficiency in the application of nanomedicine to cancer therapy.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1090845&amp;sys_siteid=305&amp;sys_contentid=1090847&amp;sys_command=edit">Massachusetts General Hospital and Harvard Univeristy &mdash; Imaging of Nanotherapeutic Drug Action</a><!-- start description -->
<div class="description">
<p class="body">In vivo imaging analyses of therapeutic nanoparticles (TNP), addressing key questions on nanoparticle distribution (pharmacokinetics, PK) and cellular response (pharmacodynamics, PD).</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=5&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1090843&amp;sys_siteid=305&amp;sys_contentid=1090850&amp;sys_command=edit">Masimo Corporation &mdash; Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance</a><!-- start description -->
<div class="description">
<p class="body">Developing a new therapeutic approach to triple negative breast cancer (TNBC) which is based on intracellular mechanical impact generated by plasmonic nanobubbles.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1091313&amp;sys_siteid=305&amp;sys_contentid=1091315&amp;sys_command=edit">The University of Texas MD Anderson Cancer Center&mdash;Targeted Therapeutics for Ovarian Cancer and its Microenvironment &ndash; Treatment and Theoretical Modeling</a><!-- start description -->
<div class="description">
<p class="body">Will offer nanotherapeutic formulations and novel approaches targeting multiple components of the tumor and its microenvironment, specifically for high-grade serous ovarian cancers.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1090841&amp;sys_siteid=305&amp;sys_contentid=1090849&amp;sys_command=edit">Ohio State University and University of Kentucky &mdash; Optimizing RNA Nanoparticle's Size and Shape for Enhancing Cancer Targeting and Treatment</a><!-- start description -->
<div class="description">
<p class="body">A systematic characterization of RNA nanoparticle behavior, in vitro and in vivo, to optimize its cellular delivery to triple negative breast cancer (TNBC).</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051410&amp;sys_siteid=305&amp;sys_contentid=1051573&amp;sys_command=edit">University of California, Davis &mdash; The Rodent Eye as a Non-Invasive Window for Understanding Cancer Nanotherapeutics</a><!-- start description -->
<div class="description">
<p class="body">This project uses the mouse eye as a non-surgical window for highly efficient, optical investigation of all aspects of syngeneic or xenograft models, using a state-of-the-art ocular imaging facility, the "EyePod."</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051412&amp;sys_siteid=305&amp;sys_contentid=1051580&amp;sys_command=edit">University of California, Los Angeles &mdash; Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer</a><!-- start description -->
<div class="description">
<p class="body">Utilizing rationally designed mesoporous silica nanoparticles (MSNP) to provide efficacious, safe and life-prolonging chemotherapy to pancreatic cancer patients.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=3&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051416&amp;sys_siteid=305&amp;sys_contentid=1051574&amp;sys_command=edit">University of California, Los Angeles &amp; Cedars-Sinai Medical Center &mdash; Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling</a><!-- start description -->
<div class="description">
<p class="body">Thermoresponsive (TR)-NanoVelcro circulating tumor cell (CTC) purification system for use in the liquid biopsy of patient response to therapeutics and cancer progression.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=3&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051402&amp;sys_siteid=305&amp;sys_contentid=1051571&amp;sys_command=edit">University of Chicago &mdash; Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers</a><!-- start description -->
<div class="description">
<p class="body">Addressing an unmet need in developing highly efficient and safe nanoparticles that can have much broader clinical applications for cancer by Near-IR triggered PDT and X-ray induced PDT (X-PDT) as well radioimmunotherapy.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051406&amp;sys_siteid=305&amp;sys_contentid=1051581&amp;sys_command=edit">University of North Carolina, Chapel Hill &mdash;Targeted Core Shell Nanogels for Triple Negative Breast Cancer</a><!-- start description -->
<div class="description">
<p class="body">Improves systemic therapies of cancer using soft nanomaterials that can penetrate deep into tumors and deliver potent anticancer agents to targeted cancer cells.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
</ul>
</div>
</div>
</div>]]></body>
  </row>
  <row id="1071499" langcode="en">
    <body><![CDATA[<div class="rxbodyfield"><br />
<h3><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1064733" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="1764" rxinlineslot="103" sys_dependentid="1064733" sys_relationshipid="7315946" sys_variantid="1764" sys_contentid="1064733">Apply for the Alliance</a></h3>
<p>NCI Alliance funding is by way of many grant mechanisms of the National Institutes of Health.&nbsp; Appliaction details for current Alliance funding is listed here.</p>
<h3><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1063327" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="1764" rxinlineslot="103" sys_dependentid="1063327" sys_relationshipid="7315947" sys_variantid="1764" sys_contentid="1063327">Research Funding</a></h3>
<p>Find specific research opportunities relevant to nanotechnology and cancer.</p>
<h3><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=7&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=1764&amp;sys_contentid=1063349" inlinetype="rxhyperlink" sys_siteid="305" sys_dependentvariantid="1764" rxinlineslot="103" sys_dependentid="1063349" sys_relationshipid="7315948" sys_variantid="1764" sys_contentid="1063349">Training Grants</a></h3>
<p>Funding for specific research and training opportunities within the field of cancer nanotechnology as well as fields that contain much cross-sectional overlap to the field.</p>
</div>]]></body>
  </row>
  <row id="1071623" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>The NCI Alliance for Nanotechnology in Cancer is an integrated, milestone driven, and product oriented program aimed at eliminating the burden of cancer.</p>
<p>Committed to building a community of researchers dedicated to using nanotechnology to advance the fight against cancer, the Alliance is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat, and prevent cancer. The Alliance works in concert with other NCI advanced technology initiatives to provide the scientific foundation and team science that is required to transform cancer research and care.</p>
<p>Launched in 2004, the National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer (Alliance) advanced a number of promising nanotechnologies for the diagnosis, treatment and prevention of cancer in its first five years. This progress led NCI to announce in September 2010 its continued support of this program with the award of five-year, multi-institution grants to generate new preventative, diagnostic and therapeutic approaches to cancer in areas where improvements cannot be realized using existing technologies. The next five years of the program aim to:</p>
<ul>
<li>rapidly advance new nanotechnology discoveries and speed their transformation into cancer-relevant applications in clinical practice</li>
<li>aid nanoparticle characterization and standardization of characterization methods to enable technology transfer from university laboratories to companies that bring these technologies to patients</li>
<li>develop the next-generation of cancer researchers in the area of nanotechnology</li>
</ul>
<p>The Alliance focused on development and translation of nanotechnology-based techniques and tools for:</p>
<ul>
<li>early disease diagnosis using in vitro (laboratory) assays and devices, and in vivo (live) imaging techniques</li>
<li>multifunctional therapeutic solutions</li>
<li>techniques for cancer prevention and control</li>
</ul>
<p>Regardless of their specific area of focus, the Alliance investigators are encouraged to concentrate their efforts on the following tumor types where the disease is characterized by low survival rates: brain, lung, ovary, and pancreas.</p>
<p>The Alliance&rsquo;s programs foster innovation and collaboration among researchers within and between institutions, as well as across scientific disciplines.</p>
<h2>Alliance Programs</h2>
<div sys_dependentvariantid="2489" sys_dependentid="1077636" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="7316026"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list">
<ul>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2289&amp;sys_context=0&amp;sys_folderid=1051374&amp;sys_siteid=305&amp;sys_contentid=1051493&amp;sys_command=edit" sys_variantid="2289" sys_contentid="1051493">Centers of Cancer Nanotechnology Excellence (CCNEs)</a><!-- start description -->
<div class="description">
<p class="body">The multi-disciplinary CCNE teams are the main venue for the discovery and tool development toward the application of nanotechnology to clinical oncology. Teams are focused on integrated technology solutions and the aggressive development of these solutions from pre-clinical to clinical application.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=3&amp;sys_authtype=0&amp;sys_variantid=2289&amp;sys_context=0&amp;sys_folderid=1051376&amp;sys_siteid=305&amp;sys_contentid=1051494&amp;sys_command=edit" sys_variantid="2289" sys_contentid="1051494">Innovative Research in Cancer Nanotechnology (IRCNs)</a><!-- start description -->
<div class="description">
<p class="body">IRCN's enable multidisciplinary, fundamental research in cancer biology and/or oncology through the use of nanotechnology</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=4&amp;sys_authtype=0&amp;sys_variantid=2289&amp;sys_context=0&amp;sys_folderid=1051388&amp;sys_siteid=305&amp;sys_contentid=1077637&amp;sys_command=edit" sys_variantid="2289" sys_contentid="1077637">Cancer Nanotechnology Training Centers (CNTCs)</a><!-- start description -->
<div class="description">
<p class="body">CNTCs are designed to establish innovative research education programs supporting the development of a multi-disciplinary nanotechnology workforce capable of pursuing cancer research.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
</ul>
</div>
</div>
<h2>Alliance Resources</h2>
<div sys_dependentvariantid="2489" sys_dependentid="1090853" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="7316027"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list">
<ul>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1051354&amp;sys_siteid=305&amp;sys_contentid=1077670&amp;sys_command=edit" sys_variantid="2297" sys_contentid="1077670">Nanotechnology Characterization Laboratory (NCL)</a><!-- start description -->
<div class="description">
<p class="body">The Nanotechnology Characterization Laboratory (NCL) is accelerating the development of promising nanotechnology therapies and diagnostics.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=3&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1051372&amp;sys_siteid=305&amp;sys_contentid=1051475&amp;sys_command=edit" sys_variantid="2287" sys_contentid="1051475">Data Sharing</a><!-- start description -->
<div class="description">
<p class="body">A well-organized, collaborative system of data sharing is critical in the translation of nanotechnology research into commercially viable therapeutics and diagnostics to treat patients.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=7&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1051440&amp;sys_siteid=305&amp;sys_contentid=1051460&amp;sys_command=edit" sys_variantid="2287" sys_contentid="1051460">Publications and Presentations</a><!-- start description -->
<div class="description">
<p class="body">The Nanodelivery Systems and Devices Branch routinely publishes reports, strategic peer-reviewed manuscripts, and subject matter expertise papers relative to our myriad of interdisciplinary backgrounds. These papers are listed on this page.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
</ul>
</div>
</div>
</div>]]></body>
  </row>
  <row id="1084646" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<h2><a href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=15&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=734&amp;sys_contentid=1064640" sys_dependentvariantid="734" sys_dependentid="1064640" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_relationshipid="7301977" sys_variantid="734" sys_contentid="1064640"></a></h2>
<div sys_dependentvariantid="2489" sys_dependentid="1142907" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="7301980"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list">
<ul>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=15&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1064638&amp;sys_siteid=305&amp;sys_contentid=1064640&amp;sys_command=edit" sys_variantid="2287" sys_contentid="1064640">NSDB News</a><!-- start description -->
<div class="description">
<p class="body">Find the latest news about NCI&rsquo;s Nanodelivery Systems and Devices Branch.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="https://percussion.cancer.gov:443/Rhythmyx/assembler/render?sys_revision=3&amp;sys_authtype=0&amp;sys_variantid=2287&amp;sys_context=0&amp;sys_folderid=1077037&amp;sys_siteid=305&amp;sys_contentid=1077041&amp;sys_command=edit" sys_variantid="2287" sys_contentid="1077041">NSDB Events</a><!-- start description -->
<div class="description">
<p class="body">Find upcoming events and past scientific conferences, meetings, and workshops where NSDB has participated.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
</ul>
</div>
</div>
</div>]]></body>
  </row>
  <row id="1097637" langcode="en">
    <body><![CDATA[<div class="rxbodyfield">
<p>CNTCs are designed to establish innovative research education programs supporting the development of a multi-disciplinary nanotechnology workforce capable of pursuing cancer research. CNTCs target graduate students and post-doctoral researchers with backgrounds in medicine, biology, and other health sciences as well as in the physical sciences, chemistry, and engineering. The program of multi-disciplinary research education in cancer nanotechnology is primarily focused on mentored laboratory-based training through participation in dedicated training research projects. This program is administered by the <a href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=187&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2317&amp;sys_contentid=16360" sys_dependentvariantid="2317" sys_dependentid="16360" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_relationshipid="6655246">NCI Center for Cancer Training</a>.</p>
<div sys_dependentvariantid="2489" sys_dependentid="1091242" inlinetype="rxvariant" rxinlineslot="105" sys_siteid="305" class="rx_ephox_inlinevariant mceNonEditable" contenteditable="false" rxselectedtext="" sys_relationshipid="6655254"><!-- cgvSnListDescriptionNoImage -->
<div class="managed list">
<ul>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1077646&amp;sys_siteid=305&amp;sys_contentid=1078433&amp;sys_command=edit">Johns Hopkins University &mdash; Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer Research</a><!-- start description -->
<div class="description">
<p class="body">Integrated predoctoral and postdoctoral training program in nanotechnology for cancer research that is positioned at the interface of medicine and technology.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1077644&amp;sys_siteid=305&amp;sys_contentid=1077662&amp;sys_command=edit">University of Texas &mdash; Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology</a><!-- start description -->
<div class="description">
<p class="body">Bridging the gap between new discoveries coming from academic labs and their translation into clinic with a multidisciplinary training program.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1077640&amp;sys_siteid=305&amp;sys_contentid=1077649&amp;sys_command=edit">Northwestern University &mdash; Cancer Nanotechnology Training Program</a><!-- start description -->
<div class="description">
<p class="body">MD- and PhD-level investigators trained in the principles and tools of nanotechnology, cancer biology, and clinical oncology with the eventual goal of applying these skills to translational research.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1077642&amp;sys_siteid=305&amp;sys_contentid=1077650&amp;sys_command=edit">Stanford University &mdash; Cancer Translational Nanotechnology Training Program</a><!-- start description -->
<div class="description">
<p class="body">Providing post-doctoral trainees with education and cross-disciplinary training to develop interdisciplinary researchers in cancer nanotechnology translation.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
<li class="general-list-item general list-item"><!-- cgvSnListItemGeneral --> <!-- Image --> <!-- End Image -->
<div class="title-and-desc title desc container"><a class="title" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=2&amp;sys_authtype=0&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_folderid=1077638&amp;sys_siteid=305&amp;sys_contentid=1077648&amp;sys_command=edit">University of North Carolina, Chapel Hill &mdash; Carolina Cancer Nanotechnology Training Program</a><!-- start description -->
<div class="description">
<p class="body">Contributing to the growth of the cancer nanotechnology workforce by providing postdoctoral training and research experiences.</p>
</div>
<!-- end description --></div>
<!-- end title & desc container --></li>
</ul>
</div>
</div>
</div>]]></body>
  </row>
  <row id="6315718" langcode="en" long_title="Research ">
    <body><![CDATA[<div class="rxbodyfield">
<ul>
<li><a class="arrow-link" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2317&amp;sys_contentid=1051623" inlinetype="rxhyperlink" sys_relationshipid="6315665" sys_folderid="" sys_siteid="305" rxinlineslot="103" sys_dependentid="1051623" sys_dependentvariantid="2317">NCI Alliance for Nanotechnology</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1064730&amp;sys_revision=1&amp;sys_variantid=734&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="734" sys_dependentid="1064730" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627702">Alliance Published Research</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1077669&amp;sys_revision=1&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="2297" sys_dependentid="1077669" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627703">NCI Alliance Companies</a></li>
<li><a class="arrow-link" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=734&amp;sys_contentid=1051475" inlinetype="rxhyperlink" sys_relationshipid="6315668" sys_folderid="" sys_siteid="305" rxinlineslot="103" sys_dependentid="1051475" sys_dependentvariantid="734">Data Sharing</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1077670&amp;sys_revision=1&amp;sys_variantid=2297&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="2297" sys_dependentid="1077670" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627704">Nanotechnology Characterization Lab</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1051489&amp;sys_revision=1&amp;sys_variantid=734&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="734" sys_dependentid="1051489" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627705">Partners &amp; Collaborators</a></li>
</ul>
</div>]]></body>
  </row>
  <row id="6399954" langcode="en" long_title="Cancer &amp; Nanotechnology">
    <body><![CDATA[<div class="rxbodyfield">
<ul>
<li><a class="arrow-link" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1074439" sys_dependentvariantid="2297" sys_dependentid="1074439" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627709">Benefits of Nanotechnology</a></li>
<li><a class="arrow-link" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1074443" sys_dependentvariantid="2297" sys_dependentid="1074443" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627710">Detection &amp; Diagnosis</a></li>
<li><a class="arrow-link" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1074446" sys_dependentvariantid="2297" sys_dependentid="1074446" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627711">Treatment &amp; Therapy</a></li>
<li><a class="arrow-link" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2297&amp;sys_contentid=1073910" sys_dependentvariantid="2297" sys_dependentid="1073910" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627712">Safety of Nanotechnology</a></li>
</ul>
<p><a class="arrow-link learn-more" href="http://percussion.cancer.gov/Rhythmyx/assembler/render?sys_revision=1&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_variantid=2317&amp;sys_contentid=1051465" sys_dependentvariantid="2317" sys_dependentid="1051465" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627713">Learn more about cancer and nanotechnology</a></p>
</div>]]></body>
  </row>
  <row id="6400038" langcode="en" long_title="Grants &amp; Training">
    <body><![CDATA[<div class="rxbodyfield">
<ul>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1064733&amp;sys_revision=1&amp;sys_variantid=734&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="734" sys_dependentid="1064733" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627699">Apply for the Alliance</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1063327&amp;sys_revision=1&amp;sys_variantid=734&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="734" sys_dependentid="1063327" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627700">Related NCI Funding &amp; Initiatives</a></li>
<li><a class="arrow-link" href="/Rhythmyx/assembler/render?sys_contentid=1063349&amp;sys_revision=1&amp;sys_variantid=734&amp;sys_context=0&amp;sys_authtype=0&amp;sys_siteid=305&amp;sys_folderid=" sys_dependentvariantid="734" sys_dependentid="1063349" inlinetype="rxhyperlink" rxinlineslot="103" sys_siteid="305" sys_folderid="" sys_relationshipid="6627701">Training Grants</a></li>
</ul>
</div>]]></body>
  </row>
</rows>